Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Atherosclerosis Reports|May 28, 2026
Patient Engagement Strategies for Implementing Evidence-Based Care in AtherosclerosisEmily E Brown, Kathleen Byrne
Journal of Community Health Nursing|May 3, 2002
Establishing partnerships with social services agencies for community health educationCarol Hall Ellenbecker, Eileen O'Brien, Kathleen Byrne
Journal of Community Health Nursing|May 3, 2002
Nursing clinics in elder housing: providing access and improving health care outcomesCarol Hall Ellenbecker, Kathleen Byrne, Eileen O'Brien, et al.
Research in Gerontological Nursing|April 5, 2013
Measurement of aggressive behaviors in dementia: comparison of the physical aggression subscales of the Cohen-Mansfield Agitation Inventory and the Ryden Aggression ScaleAnn L Whall, Hyojeong Kim, Kathleen Byrne Colling, et al.
American Journal of Preventive Cardiology|June 3, 2024
Expanded genetic testing in familial hypercholesterolemia-A single center's experienceEmily E Brown, Kathleen Byrne, Erin D Michos, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|April 30, 2005
The causes of homelessness in later life: findings from a 3-nation studyMaureen Crane, Kathleen Byrne, Ruby Fu, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
A multicentre point prevalence study of delirium assessment and management in patients admitted to Australian and New Zealand intensive care unitsMelissa J Ankravs, Andrew A Udy, Kathleen Byrne, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|February 27, 2026
A pilot, parallel-group, blinded, placebo-controlled, randomise<b>D</b>, p<b>R</b>agmatic clinical trial investigating the <b>E</b>ffect of temazep<b>AM</b> on objective and subjective measures of sleep in critically ill patients (the DREAM trial)Laurie Showler, Yasmine Ali Abdelhamid, Melissa J Ankravs, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Pageof 2